Geron intends to divest stem cell programs to BioTime; finalized
- Gene Therapy, Cell Therapy
- Intra-Biotech Deal
- Includes Contract
- Product Purchase
- Includes Equity
- Includes Royalty or Profit Split Information
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.